Search
-
GlaxoSmithKline update: A (H1N1) influenza vaccine development
Media
GSK has received orders from several governments aiming to stockpile a H1N1 adjuvanted influenza vaccine as a precautionary measure.
https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-update-a-h1n1-influenza-vaccine-development/
First published: 14 May 2009
-
H5N1 vaccine approved by the U.S. FDA as pandemic influenza preparedness measure
Media
GSK announced FDA has approved its pandemic Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted for the immunisation of adults 18+.
https://www.gsk.com/en-gb/media/press-releases/h5n1-vaccine-approved-by-the-us-fda-as-pandemic-influenza-preparedness-measure/
First published: 25 November 2013
-
GlaxoSmithKline update: A (H1N1) influenza
Media
WHO raises influenza pandemic alert to phase 6
https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-update-a-h1n1-influenza/
First published: 11 June 2009
-
Landmark New England Journal of Medicine publication reinforces potential of GSK’s respiratory syncytial virus older adult vaccine candidate
Media
First peer-reviewed publication of phase III RSV vaccine data in older adults, including those with comorbidities who are most at risk.
https://www.gsk.com/en-gb/media/press-releases/nejm-publication-reinforces-potential-of-gsk-s-respiratory-syncytial-virus-older-adult-vaccine-candidate/
First published: 15 February 2023
-
Pandemic (H1N1) 2009 influenza update
Media
GSK issued an update on H1N1 influenza virus vaccine, it's commenced the clinical development programme for its adjuvanted pandemic vaccine.
https://www.gsk.com/en-gb/media/press-releases/pandemic-h1n1-2009-influenza-update/
First published: 13 August 2009
-
FDA Approves GlaxoSmithKline’s four-strain seasonal influenza vaccine for use in the US
Media
GSK announced ,FDA has approved FLUARIX QUADRIVALENT Influenza Vaccine for the immunisation of patients to help prevent seasonal influenza
https://www.gsk.com/en-gb/media/press-releases/fda-approves-glaxosmithkline-s-four-strain-seasonal-influenza-vaccine-for-use-in-the-us/
First published: 17 December 2012
-
GSK announces first four-strain seasonal influenza vaccine granted marketing authorisation in Germany and the UK
Media
GSK has announced the marketing authorisation of its quadrivalent (four-strain) influenza vaccine in Germany and the UK.
https://www.gsk.com/en-gb/media/press-releases/gsk-announces-first-four-strain-seasonal-influenza-vaccine-granted-marketing-authorisation-in-germany-and-the-uk/
First published: 03 April 2013
-
Pandemic 2009 Influenza Update: US FDA approves GSK’s pandemic H1N1 vaccine
Media
GSK today announced that FDA has approved a sBLA for its unadjuvanted influenza A (H1N1) pandemic vaccine.
https://www.gsk.com/en-gb/media/press-releases/pandemic-2009-influenza-update-us-fda-approves-gsk-s-pandemic-h1n1-vaccine/
First published: 09 November 2009
-
New clinical data demonstrate high vaccine efficacy of Fluarix Tetra (Influenza Vaccine) in children 6-35 months of age
Media
New data published in The Lancet from a Phase III clinical trial with Fluarix Tetra which prevented influenza in children 6 to 35 months
https://www.gsk.com/en-gb/media/press-releases/new-clinical-data-demonstrate-high-vaccine-efficacy-of-fluarix-tetra-influenza-vaccine-in-children-6-35-months-of-age/
First published: 06 March 2018
-
GSK’s respiratory syncytial virus older adult vaccine candidate gains positive European Medicines Agency CHMP opinion
Media
Positive opinion advances GSK’s goal to provide the first vaccine to help protect older adults from respiratory syncytial virus disease
https://www.gsk.com/en-gb/media/press-releases/gsk-s-respiratory-syncytial-virus-older-adult-vaccine-candidate-gains-positive-european-medicines-agency-chmp-opinion/
First published: 27 April 2023